STOCK TITAN
  1. Home
  2. Sec-filings
  3. MEDP
  4. [144] Medpace Holdings, Inc. SEC Filing

Medpace (NASDAQ: MEDP) insider files for 1,140-share stock sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Medpace Holdings insider Cornelius McCarthy III filed to potentially sell 1,140 common shares through Fidelity Brokerage Services on the NASDAQ around August 11, 2026, with an indicated aggregate market value of $690,121.91. Medpace had 27,911,655 shares outstanding as of that filing line. The shares were acquired via a stock option exercise from the issuer on August 7, 2026 for cash. The filing also notes a prior sale of 795 common shares on August 7, 2026 for total proceeds of $465,131.45 over the last three months.

Positive

  • None.

Negative

  • None.
Shares proposed for sale 1,140 shares Common stock covered by the Form 144 filing
Aggregate market value $690,121.91 Indicated value of 1,140 shares proposed for sale
Shares outstanding 27,911,655 shares Medpace common shares outstanding referenced in the filing
Prior shares sold 795 shares Common shares sold during the past three months
Proceeds from prior sale $465,131.45 Aggregate proceeds from 795-share sale on August 7, 2026
Proposed sale date 08/11/2026 Anticipated sale date for the 1,140-share transaction
Acquisition date 08/07/2026 Date shares were acquired via stock option exercise
Form 144 regulatory
"144: Securities Information Common | Fidelity Brokerage"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
stock option exercise financial
"Common | 08/07/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
aggregate market value financial
"Common | Fidelity Brokerage Services LLC ... | 690121.91"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FAQ

What does Medpace (MEDP) insider Cornelius McCarthy III plan to sell under this Form 144?
The Form 144 indicates a potential sale of 1,140 Medpace common shares. These shares are to be sold through Fidelity Brokerage Services on the NASDAQ, with an indicated aggregate market value of $690,121.91 as disclosed in the filing.

When were the Medpace (MEDP) shares acquired that are covered by this Form 144?
The 1,140 Medpace shares were acquired on August 7, 2026 via a stock option exercise from the issuer. The filing notes the acquisition method as a cash-based stock option exercise, providing context for the proposed resale under Form 144.

What is the proposed timing of the Medpace (MEDP) insider share sale?
The filing lists a proposed sale date of around August 11, 2026 for the 1,140 Medpace common shares. This date in the Form 144 represents the anticipated timing for the transaction, subject to market conditions and any applicable restrictions.

How many Medpace (MEDP) shares are outstanding in relation to this Form 144 sale?
The Form 144 states that Medpace had 27,911,655 common shares outstanding. This figure provides context for the proposed 1,140-share sale, showing the filing’s transaction size relative to the company’s total shares outstanding at that time.

What Medpace (MEDP) insider sales occurred in the last three months before this Form 144?
The filing reports that 795 Medpace common shares were sold on August 7, 2026, generating aggregate proceeds of $465,131.45. This transaction is listed under securities sold during the past three months for insider Cornelius McCarthy III.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Source: View Original Filing on SEC EDGAR